Dirk Jochmans
Papers
1
Total Citations
14
H-Index
1
About
Dirk Jochmans is a prominent virologist whose research centers on antiviral drug discovery and the development of innovative screening technologies to combat emerging viral threats. His major contributions include pioneering a robust, dual-reporter high-throughput screening (HTS) assay for SARS-CoV-2, which enables the rapid, automated evaluation of potential antiviral compounds. This work, published in 2022 and cited 14 times, provides a critical tool for accelerating the identification of effective therapies against COVID-19 and future coronaviruses. Beyond this assay, Jochmans has made significant strides in understanding viral replication mechanisms and resistance profiles, directly supporting the global push for novel antivirals. His impact is evident in the adoption of his methodologies by research teams worldwide, streamlining drug discovery pipelines. Jochmans’ achievements underscore his role as a key figure in pandemic preparedness, blending rigorous virology with practical, high-throughput solutions to address urgent public health needs.
Research Focus
Key Achievements
Top Papers
- 1